We collect cookies to analyze our website traffic and performance; we never collect any personal data.Cookies Policy
Accept
Michigan Post
Search
  • Home
  • Trending
  • Michigan
  • World
  • Politics
  • Top Story
  • Business
    • Business
    • Economics
    • Real Estate
    • Startups
    • Autos
    • Crypto & Web 3
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Beauty
    • Art & Books
  • Health
  • Sports
  • Entertainment
  • Education
Reading: Ozempic maker Novo Nordisk didn’t disclose extra funds made to healthcare teams – watchdog
Share
Font ResizerAa
Michigan PostMichigan Post
Search
  • Home
  • Trending
  • Michigan
  • World
  • Politics
  • Top Story
  • Business
    • Business
    • Economics
    • Real Estate
    • Startups
    • Autos
    • Crypto & Web 3
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Beauty
    • Art & Books
  • Health
  • Sports
  • Entertainment
  • Education
© 2024 | The Michigan Post | All Rights Reserved.
Michigan Post > Blog > Tech / Science > Ozempic maker Novo Nordisk didn’t disclose extra funds made to healthcare teams – watchdog
Tech / Science

Ozempic maker Novo Nordisk didn’t disclose extra funds made to healthcare teams – watchdog

By Editorial Board Published January 27, 2025 5 Min Read
Share
Ozempic maker Novo Nordisk didn’t disclose extra funds made to healthcare teams – watchdog

The corporate behind widespread weight-loss medication didn’t disclose much more cash it paid to healthcare teams and affected person organisations , a pharmaceutical watchdog has mentioned.

Novo Nordisk – which manufactures Wegovy, Ozempic and Saxenda – misreported, under-reported or didn’t disclose funding it gave to pharmacy corporations, weight problems charities and different skilled our bodies, in accordance with the Prescription Medicines Code of Follow Authority (PMCPA).

It isn’t the primary time Novo Nordisk has didn’t disclose the funds it has made. In 2023, it admitted to the PMCPA it had not disclosed £7.8m it paid to greater than 150 organisations over three years.

A spokesperson for Novo Nordisk mentioned the organisation was “dedicated to working transparently and ethically, taking the reporting of these historical transfers of value extremely seriously”.

The brand new criticism was submitted by the College of Bathtub and Lund College and checked out £1.2m in undisclosed funds made by Novo Nordisk to healthcare and affected person organisations. A number of the funds (£609,027) had beforehand been disclosed voluntarily by the corporate in 2023.

However the newest investigation revealed that Novo Nordisk nonetheless didn’t disclose an extra £635,000 in funds. The corporate mentioned the figures submitted of their voluntary admission have been a “best estimate”.

The PMCPA mentioned the criticism “raised questions about the culture of the company and demonstrated poor governance and a lack of care”.

Funds have been additionally misattributed to the improper organisations, together with £338,435 paid to the World Weight problems Federation that was initially listed as paid to the Affiliation for British HealthTech Industries.

The investigation, led by researchers from the College of Bathtub, UK and Lund College, Sweden, uncovered numerous severe breaches of the pharmaceutical trade’s code of observe, which the watchdog upheld.

Dr Emily Rickard mentioned: “The failure to disclose payments is especially troubling, given it coincided with the UK launch of blockbuster weight-loss drugs like Wegovy. It raises serious questions about transparency and accountability.”

“We have already implemented mitigating actions to future-proof how we track and disclose transfers of value, and continue to collaborate with external partners to ensure robust systems and processes are in place,” Novo Nordisk mentioned

“This has enabled us to resubmit all relevant historical data to Disclosure UK and ensure all future transfers of value are accurately and efficiently tracked and disclosed.”

One physician referred to as for a “total overhaul” following the findings.

“When a company as large as Novo Nordisk doesn’t disclose payments, it’s not just damaging to their reputation – it undermines trust in the entire healthcare system,” mentioned Dr Piotr Ozieranski.

“Transparency in the UK’s pharmaceutical industry is transparency in name only. A total overhaul is urgently needed.”

’20 sufferers each hour’

It comes as pharmacy leaders issued a contemporary warning over the sale of weight-loss jabs within the UK, amid studies some on-line sellers have set targets for clinicians to course of greater than 20 sufferers each hour.

The Nationwide Pharmacy Affiliation (NPA) mentioned it was conscious of people that had a historical past of consuming issues, or low physique weight, being prescribed the jabs.

The NPA has written to the Basic Pharmaceutical Council saying present guidelines depart the door open for medicines to be provided with out applicable checks “and the risk to patient safety remains”.

Picture:
Pic: Reuters file picture

Weight reduction jabs, generally known as GLP-1 receptor agonists, work by lowering meals cravings. A whole bunch of hundreds of sufferers are estimated to be shopping for these medication privately by way of on-line pharmacies.

The NPA has beforehand urged sufferers towards shopping for the jabs from unregulated sellers, who could also be promoting counterfeit merchandise.

TAGGED:disclosefailedgroupshealthcaremakerNordiskNovoOzempicpaymentswatchdog
Share This Article
Facebook Twitter Email Copy Link Print

HOT NEWS

Worldwide specialists be a part of mass grave excavation at former mom and child residence in Eire

Worldwide specialists be a part of mass grave excavation at former mom and child residence in Eire

World
July 7, 2025
Lakers conform to phrases to convey again Jaxson Hayes

Lakers conform to phrases to convey again Jaxson Hayes

The Lakers and free-agent heart Jaxson Hayes have agreed up on a one-year contract for…

July 7, 2025
White Linen Pants Are the Hero of My Summer season Wardrobe—And These Are the Undisputed Finest

White Linen Pants Are the Hero of My Summer season Wardrobe—And These Are the Undisputed Finest

We could obtain a portion of gross sales if you buy a product by way…

July 7, 2025
What occurs to your pension if you die?

What occurs to your pension if you die?

What occurs to your pension financial savings if you die is determined by a number…

July 7, 2025
Detroit journalist, ex-prosecutor declare they’ve solved Jimmy Hoffa thriller

Detroit journalist, ex-prosecutor declare they’ve solved Jimmy Hoffa thriller

GRAND RAPIDS, Mich. (WOOD) — It is a (almost) 50-year-old thriller: Who killed Jimmy Hoffa…

July 7, 2025

YOU MAY ALSO LIKE

European heatwave leaves Spain, Portugal, Italy and Greece in sweltering 40C warmth

Main heatwaves throughout southern Europe have left Spain, Portugal, Italy, and Greece in sweltering situations of greater than 40C (104F).Two-thirds…

Tech / Science
July 7, 2025

Donald Trump says ‘very rich group’ has agreed to purchase TikTok within the US

Donald Trump has mentioned the US authorities has discovered a purchaser for TikTok that he'll reveal "in about two weeks".…

Tech / Science
July 7, 2025

Intestine micro organism linked to fertility points in girls with polycystic ovary syndrome, analysis signifies

Girls with polycystic ovary syndrome (PCOS) have decrease ranges of a intestine microbe, new analysis suggests.PCOS is the commonest hormonal…

Tech / Science
July 7, 2025

Jackets laced with water pipes and good bottles – the tech options to the heatwave

Heatwaves and scorching days might typically be described as "good weather", however warmth can have a harmful impact on the…

Tech / Science
July 7, 2025

Welcome to Michigan Post, an esteemed publication of the Enspirers News Group. As a beacon of excellence in journalism, Michigan Post is committed to delivering unfiltered and comprehensive news coverage on World News, Politics, Business, Tech, and beyond.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement

Contact Us

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 | The Michigan Post | All Rights Reserved

Welcome Back!

Sign in to your account

Lost your password?